Thyroid stem cells and cancer

Thyroid

Volumn 19, Issue 12, 2009, Pages 1303-1315

  Klonisch, Thomas ^a,b   Hoang Vu, Cuong ^c   Hombach Klonisch, Sabine ^a,b  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MARKER;

ADULT STEM CELL; BONE MARROW; EMBRYONIC STEM CELL; HUMAN; MICROCHIMERISM; NONHUMAN; ORGANOGENESIS; PRIORITY JOURNAL; REVIEW; THYROID CANCER; THYROID CELL; TISSUE REGENERATION;

ADULT; ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BONE MARROW CELLS; CELL DIFFERENTIATION; CHIMERISM; EMBRYONIC STEM CELLS; HUMANS; MICE; OCTAMER TRANSCRIPTION FACTOR-3; STEM CELLS; THYROID GLAND; THYROID NEOPLASMS;

EID: 75449101148     PISSN: 10507256     EISSN: None     Source Type: Journal    
DOI: 10.1089/thy.2009.1604     Document Type: Review

References (160)

1. Filip S, English D, Mokry J 2004 Issues in stem cell plasticity. J Cell Mol Med 8:572-577.
2. Mimeault M, Hauke R, Mehta PP, Batra SK 2007 Recent advances in cancer stem=progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers. J Cell Mol Med 11:981-1011.
3. Hombach-Klonisch S, Panigrahi S, Rashedi I, Seifert A, Alberti E, Pocar P, Kurpisz M, Schulze-Osthoff K, Mackiewicz A, Los M 2008 Adult stem cells and their transdifferentiation potential-perspectives and therapeutic applications. J Mol Med 86:1301-1314.
4. Klonisch T, Wiechec E, Hombach-Klonisch S, Ande SR, Wesselborg S, Schulze-Osthoff K, Los M 2008 Cancer stem cell markers in common cancers-therapeutic implications. Trends Mol Med 14:450-460.
5. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ 2007 Cancer statistics, 2007. CA Cancer J Clin 57:43-66.
6. Davies L, Welch HG 2006 Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 295:2164-2167.
7. de Groot JW, Links TP, Plukker JT, Lips CJ, HofstraRM 2006 RET as a diagnostic and therapeutic target in sporadic and hereditary endocrine tumors. Endocr Rev 27:535-560.
8. Kondo T, Ezzat S, Asa SL 2006 Pathogenetic mechanisms in thyroid follicular-cell neoplasia. Nat Rev Cancer 6:292-306.
9. Smallridge RC, Marlow LA, Copland JA 2009 Anaplastic thyroid cancer: molecular pathogenesis and emerging therapies. Endocr Relat Cancer 16:17-44.
10. Le Douarin N, Fontaine J, Le Lievre C 1974 New studies on the neural crest origin of the avian ultimobranchial glandular cells-interspecific combinations and cytochemical characterization of C cells based on the uptake of biogenic amine precursors. Histochemistry 38:297-305.
11. Fontaine J 1979 Multistep migration of calcitonin cell precursors during ontogeny of the mouse pharynx. Gen Comp Endocrinol 37:81-92.
12. Zorn AM, Wells JM 2007 Molecular basis of vertebrate endoderm development. Int Rev Cytol 259:49-111.
13. Kimelman D, Griffin KJ 2000 Vertebrate mesendoderm induction and patterning. Curr Opin Genet Dev 10:350-356.
14. Rodaway A, Patient R 2001 Mesendoderm. An ancient germ layer? Cell 105:169-172.
15. Lawson KA, Pedersen RA 1987 Cell fate, morphogenetic movement and population kinetics of embryonic endoderm at the time of germ layer formation in the mouse. Development 101:627-652.
16. Lawson KA, Meneses JJ, Pedersen RA 1991 Clonal analysis of epiblast fate during germ layer formation in the mouse embryo. Development 113:891-911.
17. Ninomiya H, Takahashi S, Tanegashima K, Yokota C, Asashima M 1999 Endoderm differentiation and inductive effect of activin-treated ectoderm in Xenopus. Dev Growth Differ 41:391-400.
18. Norris DP, Robertson EJ 1999 Asymmetric and nodespecific nodal expression patterns are controlled by two distinct cis-acting regulatory elements. Genes Dev 13:1575-1588.
19. Morkel M, Huelsken J, Wakamiya M, Ding J, van de Wetering M, Clevers H, Taketo MM, Behringer RR, Shen MM, Birchmeier W 2003 Beta-catenin regulates Cripto-and Wnt3-dependent gene expression programs in mouse axis and mesoderm formation. Development 130:6283-6294.
20. Yamamoto M, Saijoh Y, Perea-Gomez A, Shawlot W, Behringer RR, Ang SL, Hamada H, Meno C 2004 Nodal antagonists regulate formation of the anteroposterior axis of the mouse embryo. Nature 428:387-392.
21. Kubo A, Shinozaki K, Shannon JM, Kouskoff V, Kennedy M, Woo S, Fehling HJ, Keller G 2004 Development of definitive endoderm from embryonic stem cells in culture. Development 131:1651-1662.
22. Lazzaro D, Price M, de Felice M, Di Lauro R 1991 The transcription factor TTF-1 is expressed at the onset of thyroid and lung morphogenesis and in restricted regions of the foetal brain. Development 113:1093-1104.
23. De Felice M, Postiglione MP, Di Lauro R 2004 Minireview: thyrotropin receptor signaling in development and differentiation of the thyroid gland: insights from mouse models and human diseases. Endocrinology 145:4062-4067.
24. Postiglione MP, Parlato R, Rodriguez-Mallon A, Rosica A, Mithbaokar P, Maresca M, Marians RC, Davies TF, Zannini MS, De Felice M, Di Lauro R 2002 Role of the thyroidstimulating hormone receptor signaling in development and differentiation of the thyroid gland. Proc Natl Acad Sci USA 99:15462-15467.
25. Beamer WJ, Eicher EM, Maltais LJ, Southard JL 1981 Inherited primary hypothyroidism in mice. Science 212: 61-63.
26. Gu WX, Du GG, Kopp P, Rentoumis A, Albanese C, Kohn LD, Madison LD, Jameson JL 1995 The thyrotropin (TSH) receptor transmembrane domain mutation (Pro556-Leu) in the hypothyroid hyt=hyt mouse results in plasma membrane targeting but defective TSH binding. Endocrinology 136:3146-3153.
27. Li S, Crenshaw EB, 3rd, Rawson EJ, Simmons DM, Swanson LW, Rosenfeld MG 1990 Dwarf locus mutants lacking three pituitary cell types result from mutations in the POUdomain gene pit-1. Nature 347:528-533.
28. De Felice M, Di Lauro R 2004 Thyroid development and its disorders: genetics and molecular mechanisms. Endocr Rev 25:722-746.
29. Serls AE, Doherty S, Parvatiyar P, Wells JM, Deutsch GH 2005 Different thresholds of fibroblast growth factors pattern the ventral foregut into liver and lung. Development 132:35-47.
30. Que J, Okubo T, Goldenring JR, Nam KT, Kurotani R, Morrisey EE, Taranova O, Pevny LH, Hogan BL 2007 Multiple dose-dependent roles for Sox2 in the patterning and differentiation of anterior foregut endoderm. Development 134:2521-2531.
31. Revest JM, Spencer-Dene B, Kerr K, De Moerlooze L, Rosewell I, Dickson C 2001 Fibroblast growth factor receptor 2-IIIb acts upstream of Shh and Fgf4 and is required for limb bud maintenance but not for the induction of Fgf8, Fgf10, Msx1, or Bmp4. Dev Biol 231:47-62.
32. Ohuchi H, Hori Y, Yamasaki M, Harada H, Sekine K, Kato S, Itoh N 2000 FGF10 acts as a major ligand for FGF receptor 2 IIIb in mouse multi-organ development. Biochem Biophys Res Commun 277:643-649.
33. Celli G, LaRochelle WJ, Mackem S, Sharp R, Merlino G 1998 Soluble dominant-negative receptor uncovers essential roles for fibroblast growth factors in multi-organ induction and patterning. EMBO J 17:1642-1655.
34. Fagman H, Grande M, Edsbagge J, Semb H, Nilsson M 2003 Expression of classical cadherins in thyroid development: maintenance of an epithelial phenotype throughout organogenesis. Endocrinology 144:3618-3624.
35. Kusakabe T, Hoshi N, Kimura S 2006 Origin of the ultimobranchial body cyst: T=ebp=Nkx2.1 expression is required for development and fusion of the ultimobranchial body to the thyroid. Dev Dyn 235:1300-1309.
36. Harach HR 1988 Solid cell nests of the thyroid. J Pathol 155:191-200.
37. Reis-Filho JS, Preto A, Soares P, Ricardo S, Cameselle-Teijeiro J, Sobrinho-Simoes M 2003 p63 expression in solid cell nests of the thyroid: further evidence for a stem cell origin. Mod Pathol 16:43-48.
38. Preto A, Cameselle-Teijeiro J, Moldes-Boullosa J, Soares P, Cameselle-Teijeiro JF, Silva P, Reis-Filho JS, Reyes-Santias RM, Alfonsin-Barreiro N, Forteza J, Sobrinho-Simoes M 2004 Telomerase expression and proliferative activity suggest a stem cell role for thyroid solid cell nests. Mod Pathol 17:819-826.
39. Desbaillets I, Ziegler U, Groscurth P, Gassmann M 2000 Embryoid bodies: an in vitro model of mouse embryogenesis. Exp Physiol 85:645-651.
40. Trounson A 2006 The production and directed differentiation of human embryonic stem cells. Endocr Rev 27:208-219.
41. Lin RY, Kubo A, Keller GM, Davies TF 2003 Committing embryonic stem cells to differentiate into thyrocyte-like cells in vitro. Endocrinology 144:2644-2649.
42. Lin RY, Davies TF 2006 Derivation and characterization of thyrocyte-like cells from embryonic stem cells in vitro. Methods Mol Biol 330:249-261.
43. Arufe MC, Lu M, Lin RY 2009 Differentiation of murine embryonic stem cells to thyrocytes requires insulin and insulin-like growth factor-1. Biochem Biophys Res Commun 381:264-270.
44. Ma R, Latif R, Davies TF 2009 Thyrotropin-independent induction of thyroid endoderm from embryonic stem cells by activin A. Endocrinology 150:1970-1975.
45. D'Amour KA, Agulnick AD, Eliazer S, Kelly OG, Kroon E, Baetge EE 2005 Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat Biotechnol 23:1534-1541.
46. Coclet J, Foureau F, Ketelbant P, Galand P, Dumont JE 1989 Cell population kinetics in dog and human adult thyroid. Clin Endocrinol (Oxf) 31:655-665.
47. Dumont JE, Lamy F, Roger P, Maenhaut C 1992 Physiological and pathological regulation of thyroid cell proliferation and differentiation by thyrotropin and other factors. Physiol Rev 72:667-697.
48. Derwahl M, Studer H 2002 Hyperplasia versus adenoma in endocrine tissues: are they different? Trends Endocrinol Metab 13:23-28.
49. Krohn K, Fuhrer D, Bayer Y, Eszlinger M, Brauer V, Neumann S, Paschke R 2005 Molecular pathogenesis of euthyroid and toxic multinodular goiter. Endocr Rev 26:504-524.
50. Peter HJ, Gerber H, Studer H, Smeds S 1985 Pathogenesis of heterogeneity in human multinodular goiter. A study on growth and function of thyroid tissue transplanted onto nude mice. J Clin Invest 76:1992-2002.
51. Thomas T, Nowka K, Lan L, Derwahl M 2006 Expression of endoderm stem cell markers: evidence for the presence of adult stemcells in human thyroid glands. Thyroid 16:537-544.
52. Lan L, Cui D, Nowka K, Derwahl M 2007 Stem cells derived from goiters in adults form spheres in response to intense growth stimulation and require thyrotropin for differentiation into thyrocytes. J Clin Endocrinol Metab 92:3681-3688.
53. Fierabracci A, Puglisi MA, Giuliani L, Mattarocci S, Gallinella-Muzi M 2008 Identification of an adult stem= progenitor cell-like population in the human thyroid. J Endocrinol 198:471-487.
54. Toda S, Watanabe K, Yokoi F, Matsumura S, Suzuki K, Ootani A, Aoki S, Koike N, Sugihara H 2002 A new organotypic culture of thyroid tissue maintains three-dimensional follicles with C cells for a long term. Biochem Biophys Res Commun 294:906-911.
55. Toda S, Koike N, SugiharaH2001 Thyrocyte integration, and thyroid folliculogenesis and tissue regeneration: perspective for thyroid tissue engineering. Pathol Int 51:403-417. (Pubitemid 32646205)
56. De Tullio R, Averna M, Salamino F, Pontremoli S, Melloni E 2000 Differential degradation of calpastatin by mu-and m-calpain in Ca(2+)-enriched human neuroblastoma LAN-5 cells. FEBS Lett 475:17-21.
57. Greiner DL, Hesselton RA, Shultz LD 1998 SCID mouse models of human stem cell engraftment. Stem Cells 16:166-177.
58. Hoshi N, Kusakabe T, Taylor BJ, Kimura S 2007 Side population cells in the mouse thyroid exhibit stem=progenitor cell-like characteristics. Endocrinology 148:4251-4258.
59. Tsai RY, McKay RD 2002 A nucleolar mechanism controlling cell proliferation in stem cells and cancer cells. Genes Dev 16:2991-3003.
60. Niwa H, Miyazaki J, Smith AG 2000 Quantitative expression of Oct-3=4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 24:372-376.
61. Xin L, Lawson DA, Witte ON 2005 The Sca-1 cell surface marker enriches for a prostate-regenerating cell subpopulation that can initiate prostate tumorigenesis. Proc Natl Acad Sci USA 102:6942-6947.
62. van de Rijn M, Heimfeld S, Spangrude GJ, Weissman IL 1989 Mouse hematopoietic stem-cell antigen Sca-1 is a member of the Ly-6 antigen family. Proc Natl Acad Sci USA 86:4634-4638.
63. Wulf GG, Luo KL, Jackson KA, Brenner MK, Goodell MA 2003 Cells of the hepatic side population contribute to liver regeneration and can be replenished with bone marrow stem cells. Haematologica 88:368-378.
64. Sherwood RI, Christensen JL, Weissman IL, Wagers AJ 2004 Determinants of skeletal muscle contributions from circulating cells, bone marrow cells, and hematopoietic stem cells. Stem Cells 22:1292-1304.
65. Cohen A, Rovelli A, Merlo DF, van Lint MT, Lanino E, Bresters D, Ceppi M, Bocchini V, Tichelli A, Socie G 2007 Risk for secondary thyroid carcinoma after hematopoietic stem-cell transplantation: an EBMT Late Effects Working Party Study. J Clin Oncol 25:2449-2454.
66. Sanders JE, Hoffmeister PA, Woolfrey AE, Carpenter PA, Storer BE, Storb RF, Appelbaum FR 2009 Thyroid function following hematopoietic cell transplantation in children: 30 years' experience. Blood 113:306-308.
67. Liegeois A, Escourrou J, Ouvre E, Charreire J 1977 Microchimerism: a stable state of low-ratio proliferation of allogeneic bone marrow. Transplant Proc 9:273-276.
68. Wang Y, Iwatani H, Ito T, Horimoto N, Yamato M, Matsui I, Imai E, Hori M 2004 Fetal cells in mother rats contribute to the remodeling of liver and kidney after injury. Biochem Biophys Res Commun 325:961-967.
69. Turin L, Tribbioli G, Invernizzi P, Grati FR, Crema S, Laible G, Riva F 2007 Fetal microchimerism in normal and embryo transfer bovine pregnancies. Vet Res Commun 31 Suppl 1:205-207.
70. Jimenez DF, Leapley AC, Lee CI, Ultsch MN, Tarantal AF 2005 Fetal CD34+ cells in the maternal circulation and long-term microchimerism in rhesus monkeys (Macaca mulatta). Transplantation 79:142-146.
71. Lo YM, Patel P, Sampietro M, Gillmer MD, Fleming KA, Wainscoat JS 1990 Detection of single-copy fetal DNA sequence from maternal blood. Lancet 335:1463-1464.
72. Klonisch T, Drouin R 2009 Fetal-maternal exchange of multipotent stem=progenitor cells: microchimerism in diagnosis and diseases. Trends Mol Med 15:510-518.
73. Thomas MR, Williamson R, Craft I, Yazdani N, Rodeck CH 1994 Y chromosome sequence DNA amplified from peripheral blood of women in early pregnancy. Lancet 343:413-414.
74. Ariga H, Ohto H, Busch MP, Imamura S, Watson R, Reed W, Lee TH 2001 Kinetics of fetal cellular and cell-free DNA in the maternal circulation during and after pregnancy: implications for noninvasive prenatal diagnosis. Transfusion 41:1524-1530.
75. Bianchi DW, Farina A, Weber W, Delli-Bovi LC, Deriso M, Williams JM, Klinger KW 2001 Significant fetal-maternal hemorrhage after termination of pregnancy: implications for development of fetal cell microchimerism. Am J Obstet Gynecol 184:703-706.
76. Bianchi DW, Williams JM, Sullivan LM, Hanson FW, Klinger KW, Shuber AP 1997 PCR quantitation of fetal cells in maternal blood in normal and aneuploid pregnancies. Am J Hum Genet 61:822-829.
77. Bianchi DW, Zickwolf GK, Weil GJ, Sylvester S, DeMaria MA 1996 Male fetal progenitor cells persist in maternal blood for as long as 27 years postpartum. Proc Natl Acad Sci USA 93:705-708.
78. Campagnoli C, Roberts IA, Kumar S, Bennett PR, Bellantuono I, Fisk NM 2001 Identification of mesenchymal stem=progenitor cells in human first-trimester fetal blood, liver, and bone marrow. Blood 98:2396-2402.
79. Mikhail MA, M'Hamdi H, Welsh J, Levicar N, Marley SB, Nicholls JP, Habib NA, Louis LS, Fisk NM, Gordon MY2008 High frequency of fetal cells within a primitive stem cell population in maternal blood. Hum Reprod 23:928-933.
80. Nguyen Huu S, Dubernard G, Aractingi S, Khosrotehrani K 2006 Feto-maternal cell trafficking: a transfer of pregnancy associated progenitor cells. Stem Cell Rev 2:111-116.
81. Renne C, Ramos Lopez E, Steimle-Grauer SA, Ziolkowski P, Pani MA, Luther C, Holzer K, Encke A, Wahl RA, Bechstein WO, Usadel KH, Hansmann ML, Badenhoop K 2004 Thyroid fetal male microchimerisms in mothers with thyroid disorders: presence of Y-chromosomal immunofluorescence in thyroid-infiltrating lymphocytes is more prevalent in Hashimoto's thyroiditis and Graves' disease than in follicular adenomas. J Clin Endocrinol Metab 89:5810-5814.
82. Srivatsa B, Srivatsa S, Johnson KL, Samura O, Lee SL, Bianchi DW 2001 Microchimerism of presumed fetal origin in thyroid specimens from women: a case-control study. Lancet 358:2034-2038.
83. Koopmans M, Kremer Hovinga IC, Baelde HJ, Harvey MS, de Heer E, Bruijn JA, Bajema IM 2008 Chimerism occurs in thyroid, lung, skin and lymph nodes of women with sons. J Reprod Immunol 78:68-75.
84. Imaizumi M, Pritsker A, Unger P, Davies TF 2002 Intrathyroidal fetal microchimerism in pregnancy and postpartum. Endocrinology 143:247-253. (Pubitemid 34056426)
85. Klintschar M, Schwaiger P, Mannweiler S, Regauer S, Kleiber M 2001 Evidence of fetal microchimerism in Hashimoto's thyroiditis. J Clin Endocrinol Metab 86:2494-2498.
86. Cameselle-Teijeiro J, Varela-Duran J, Sambade C, Villanueva JP, Varela-Nunez R, Sobrinho-Simoes M 1994 Solid cell nests of the thyroid: light microscopy and immunohistochemical profile. Hum Pathol 25:684-693.
87. Beckner ME, Shultz JJ, Richardson T 1990 Solid and cystic ultimobranchial body remnants in the thyroid. Arch Pathol Lab Med 114:1049-1052.
88. Burstein DE, Nagi C, Wang BY, Unger P 2004 Immunohistochemical detection of p53 homolog p63 in solid cell nests, papillary thyroid carcinoma, and Hashimoto's thyroiditis: a stem cell hypothesis of papillary carcinoma oncogenesis. Hum Pathol 35:465-473.
89. Harach HR 1987 Mixed follicles of the human thyroid gland. Acta Anat (Basel) 129:27-30.
90. Yang A, Kaghad M, Wang Y, Gillett E, Fleming MD, Dotsch V, Andrews NC, Caput D, McKeon F 1998 p63, a p53 homolog at 3q27-29, encodes multiple products with transactivating, death-inducing, and dominant-negative activities. Mol Cell 2:305-316.
91. Yang A, McKeon F 2000 P63 and P73: P53 mimics, menaces and more. Nat Rev Mol Cell Biol 1:199-207.
92. Pellegrini G, Dellambra E, Golisano O, Martinelli E, Fantozzi I, Bondanza S, Ponzin D, McKeon F, De Luca M 2001 p63 identifies keratinocyte stem cells. Proc Natl Acad Sci USA 98:3156-3161.
93. Mills AA, Zheng B, Wang XJ, Vogel H, Roop DR, Bradley A 1999 p63 is a p53 homologue required for limb and epidermal morphogenesis. Nature 398:708-713.
94. Yang A, Schweitzer R, Sun D, Kaghad M, Walker N, Bronson RT, Tabin C, Sharpe A, Caput D, Crum C, McKeon F 1999 p63 is essential for regenerative proliferation in limb, craniofacial and epithelial development. Nature 398:714-718.
95. Faggiano A, Talbot M, Baudin E, Bidart JM, Schlumberger M, Caillou B 2003 Differential expression of galectin 3 in solid cell nests and C cells of human thyroid. J Clin Pathol 56:142-143.
96. Nikiforova MN, Kimura ET, Gandhi M, Biddinger PW, Knauf JA, Basolo F, Zhu Z, Giannini R, Salvatore G, Fusco A, Santoro M, Fagin JA, Nikiforov YE 2003 BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas. J Clin Endocrinol Metab 88:5399-5404.
97. Jhiang SM, Sagartz JE, Tong Q, Parker-Thornburg J, Capen CC, Cho JY, Xing S, Ledent C 1996 Targeted expression of the ret=PTC1 oncogene induces papillary thyroid carcinomas. Endocrinology 137:375-378. (Pubitemid 26005013)
98. Portella G, Vitagliano D, Borselli C, Melillo RM, Salvatore D, Rothstein JL, Vecchio G, Fusco A, Santoro M 1999 Human N-ras, TRK-T1, and RET=PTC3 oncogenes, driven by a thyroglobulin promoter, differently affect the expression of differentiation markers and the proliferation of thyroid epithelial cells. Oncol Res 11:421-427.
99. Moniz S, Catarino AL, Marques AR, Cavaco B, Sobrinho L, Leite V 2002 Clonal origin of non-medullary thyroid tumours assessed by non-random X-chromosome inactivation. Eur J Endocrinol 146:27-33.
100. Pagani F, Zagato L, Vergani C, Casari G, Sidoli A, Baralle FE 1991 Tissue-specific splicing pattern of fibronectin messenger RNA precursor during development and aging in rat. J Cell Biol 113:1223-1229.
101. Takano T, Matsuzuka F, Miyauchi A, Yokozawa T, Liu G, Morita S, Kuma K, Amino N 1998 Restricted expression of oncofetal fibronectin mRNA in thyroid papillary and anaplastic carcinoma: an in situ hybridization study. Br J Cancer 78:221-224.
102. Zhang P, Zuo H, Ozaki T, Nakagomi N, Kakudo K 2006 Cancer stem cell hypothesis in thyroid cancer. Pathol Int 56:485-489.
103. Huang Y, Prasad M, Lemon WJ, Hampel H, Wright FA, Kornacker K, LiVolsi V, Frankel W, Kloos RT, Eng C, Pellegata NS, de la Chapelle A 2001 Gene expression in papillary thyroid carcinoma reveals highly consistent profiles. Proc Natl Acad Sci USA 98:15044-15049.
104. Takano T 2004 Fetal cell carcinogenesis of the thyroid: a hypothesis for better understanding of gene expression profile and genomic alternation in thyroid carcinoma. Endocr J 51:509-515.
105. Takano T, Amino N 2005 Fetal cell carcinogenesis: a new hypothesis for better understanding of thyroid carcinoma. Thyroid 15:432-438.
106. Hombach-Klonisch S, Paranjothy T, Wiechec E, Pocar P, Mustafa T, Seifert A, Zahl C, Gerlach KL, Biermann K, Steger K, Hoang-Vu C, Schulze-Osthoff K, Los M 2008 Cancer stem cells as targets for cancer therapy: selected cancers as examples. Arch Immunol Ther Exp (Warsz) 56:165-180.
107. Takano T 2007 Fetal cell carcinogenesis of the thyroid: theory and practice. Semin Cancer Biol 17:233-240.
108. MitsutakeN, IwaoA,Nagai K,Namba H, OhtsuruA, Saenko V, Yamashita S 2007 Characterization of side population in thyroid cancer cell lines: cancer stem-like cells are enriched partly but not exclusively. Endocrinology 148:1797-1803.
109. Zito G, Richiusa P, Bommarito A, Carissimi E, Russo L, Coppola A, Zerilli M, Rodolico V, Criscimanna A, Amato M, Pizzolanti G, Galluzzo A, Giordano C 2008 In vitro identification and characterization of CD133(pos) cancer stem-like cells in anaplastic thyroid carcinoma cell lines. PLoS One 3:e3544.
110. Friedman S, Lu M, Schultz A, Thomas D, Lin RY 2009 CD133+ anaplastic thyroid cancer cells initiate tumors in immunodeficient mice and are regulated by thyrotropin. PLoS One 4:e5395.
111. Schweppe RE, Klopper JP, Korch C, Pugazhenthi U, Benezra M, Knauf JA, Fagin JA, Marlow LA, Copland JA, Smallridge RC, Haugen BR 2008 Deoxyribonucleic acid profiling analysis of 40 human thyroid cancer cell lines reveals cross-contamination resulting in cell line redundancy and misidentification. J Clin Endocrinol Metab 93:4331-4341.
112. Ginestier C, Hur MH, Charafe-Jauffret E, Monville F, Dutcher J, Brown M, Jacquemier J, Viens P, Kleer CG, Liu S, Schott A, Hayes D, Birnbaum D, Wicha MS, Dontu G 2007 ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 1:555-567.
113. Matsui W, Huff CA, Wang Q, Malehorn MT, Barber J, Tanhehco Y, Smith BD, Civin CI, Jones RJ 2004 Characterization of clonogenic multiple myeloma cells. Blood 103:2332-2336.
114. Pearce DJ, Taussig D, Simpson C, Allen K, Rohatiner AZ, Lister TA, Bonnet D 2005 Characterization of cells with a high aldehyde dehydrogenase activity from cord blood and acute myeloid leukemia samples. Stem Cells 23:752-760.
115. Sawicki JA 2008 Fetal microchimerism and cancer. Cancer Res 68:9567-9569.
116. Yu J, Ren X, Cao S, Li H, Hao X 2008 Beneficial effects of fetal-maternal microchimerism on the activated haploidentical peripheral blood stem cell treatment for cancer. Cytotherapy 10:331-339.
117. Gilmore GL, Haq B, Shadduck RK, Jasthy SL, Lister J 2008 Fetal-maternal microchimerism in normal parous females and parous female cancer patients. Exp Hematol 36:1073-1077.
118. Cirello V, Recalcati MP, Muzza M, Rossi S, Perrino M, Vicentini L, Beck-Peccoz P, Finelli P, Fugazzola L 2008 Fetal cell microchimerism in papillary thyroid cancer: a possible role in tumor damage and tissue repair. Cancer Res 68: 8482-8488.
119. Dubernard G, Oster M, Chareyre F, Antoine M, Rouzier R, Uzan S, Aractingi S, Khosrotehrani K 2009 Increased fetal cell microchimerism in high grade breast carcinomas occurring during pregnancy. Int J Cancer 124:1054-1059.
120. Nguyen Huu S, Khosrotehrani K, Oster M, Moguelet P, Espie MJ, Aractingi S 2008 Early phase of maternal skin carcinogenesis recruits long-term engrafted fetal cells. Int J Cancer 123:2512-2517.
121. Aractingi S, Kanitakis J, Euvrard S, Le Danff C, Peguillet I, Khosrotehrani K, Lantz O, Carosella ED 2005 Skin carcinoma arising from donor cells in a kidney transplant recipient. Cancer Res 65:1755-1760.
122. Cameselle-Teijeiro J, Febles-Perez C, Sobrinho-Simoes M 1995 Papillary and mucoepidermoid carcinoma of the thyroid with anaplastic transformation: a case report with histologic and immunohistochemical findings that support a provocative histogenetic hypothesis. Pathol Res Pract 191:1214-1221.
123. Malaguarnera R, Mandarino A, Mazzon E, Vella V, Gangemi P, Vancheri C, Vigneri P, Aloisi A, Vigneri R, Frasca F 2005 The p53-homologue p63 may promote thyroid cancer progression. Endocr Relat Cancer 12:953-971.
124. Zhou S, Schuetz JD, Bunting KD, Colapietro AM, Sampath J, Morris JJ, Lagutina I, Grosveld GC, Osawa M, Nakauchi H, Sorrentino BP 2001 The ABC transporter Bcrp1=ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype. Nat Med 7:1028-1034.
125. Hirschmann-Jax C, Foster AE, Wulf GG, Nuchtern JG, Jax TW, Gobel U, Goodell MA, Brenner MK 2004 A distinct "side population" of cells with high drug efflux capacity in human tumor cells. Proc Natl Acad Sci USA 101:14228-14233.
126. Liu G, Yuan X, Zeng Z, Tunici P, Ng H, Abdulkadir IR, Lu L, Irvin D, Black KL, Yu JS 2006 Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma. Mol Cancer 5:67-79.
127. Woodward WA, Chen MS, Behbod F, Alfaro MP, Buchholz TA, Rosen JM 2007 WNT=beta-catenin mediates radiation resistance of mouse mammary progenitor cells. Proc Natl Acad Sci USA 104:618-623.
128. Rao AS, Kremenevskaja N, von Wasielewski R, Jakubcakova V, Kant S, Resch J, Brabant G 2006 Wnt=beta-catenin signaling mediates antineoplastic effects of imatinib mesylate (gleevec) in anaplastic thyroid cancer. J Clin Endocrinol Metab 91:159-168.
129. Dziba JM, Ain KB 2004 Imatinib mesylate (gleevec; STI571) monotherapy is ineffective in suppressing human anaplastic thyroid carcinoma cell growth in vitro. J Clin Endocrinol Metab 89:2127-2135.
130. de Martimprey H, Bertrand JR, Fusco A, Santoro M, Couvreur P, Vauthier C, Malvy C 2008 siRNA nanoformulation against the ret=PTC1 junction oncogene is efficient in an in vivo model of papillary thyroid carcinoma. Nucleic Acids Res 36:e2.
131. Deshpande HA, Gettinger SN, Sosa JA 2008 Novel chemotherapy options for advanced thyroid tumors: small molecules offer great hope. Curr Opin Oncol 20:19-24.
132. Mansouri A, Chowdhury K, Gruss P 1998 Follicular cells of the thyroid gland require Pax8 gene function. Nat Genet 19:87-90.
133. Kimura S, Hara Y, Pineau T, Fernandez-Salguero P, Fox CH, Ward JM, Gonzalez FJ 1996 The T=ebp null mouse: thyroid-specific enhancer-binding protein is essential for the organogenesis of the thyroid, lung, ventral forebrain, and pituitary. Genes Dev 10:60-69.
134. Martinez Barbera JP, Clements M, Thomas P, Rodriguez T, Meloy D, Kioussis D, Beddington RS 2000 The homeobox gene Hex is required in definitive endodermal tissues for normal forebrain, liver and thyroid formation. Development 127:2433-2445.
135. De Felice M, Ovitt C, Biffali E, Rodriguez-Mallon A, Arra C, Anastassiadis K, Macchia PE, Mattei MG, Mariano A, Scholer H, Macchia V, Di Lauro R 1998 A mouse model for hereditary thyroid dysgenesis and cleft palate. Nat Genet 19:395-398.
136. Kameda Y, Ito M, Nishimaki T, Gotoh N 2009 FRS2alpha is required for the separation, migration, and survival of pharyngeal-endoderm derived organs including thyroid, ultimobranchial body, parathyroid, and thymus. Dev Dyn 238:503-513.
137. Xu PX, Zheng W, Laclef C, Maire P, Maas RL, Peters H, Xu X 2002 Eya1 is required for the morphogenesis of mammalian thymus, parathyroid and thyroid. Development 129:3033-3044.
138. Manley NR, Capecchi MR 1995 The role of Hoxa-3 in mouse thymus and thyroid development. Development 121:1989-2003.
139. Peters H, Neubuser A, Kratochwil K, Balling R 1998 Pax9-deficient mice lack pharyngeal pouch derivatives and teeth and exhibit craniofacial and limb abnormalities. Genes Dev 12:2735-2747.
140. Meunier D, Aubin J, Jeannotte L 2003 Perturbed thyroid morphology and transient hypothyroidism symptoms in Hoxa5 mutant mice. Dev Dyn 227:367-378.
141. Rochefort P, Caillou B, Michiels FM, Ledent C, Talbot M, Schlumberger M, Lavelle F, Monier R, Feunteun J 1996 Thyroid pathologies in transgenic mice expressing a human activated Ras gene driven by a thyroglobulin promoter. Oncogene 12:111-118.
142. Russell JP, Powell DJ, Cunnane M, Greco A, Portella G, Santoro M, Fusco A, Rothstein JL 2000 The TRK-T1 fusion protein induces neoplastic transformation of thyroid epithelium. Oncogene 19:5729-5735.
143. La Perle KM, Jhiang SM, Capen CC 2000 Loss of p53 promotes anaplasia and local invasion in ret=PTC1-induced thyroid carcinomas. Am J Pathol 157:671-677.
144. Powell DJ Jr., Russell J, Nibu K, Li G, Rhee E, Liao M, Goldstein M, Keane WM, Santoro M, Fusco A, Rothstein JL 1998 The RET=PTC3 oncogene: metastatic solid-type papillary carcinomas in murine thyroids. Cancer Res 58:5523-5528.
145. Powell DJ Jr., Russell JP, Li G, Kuo BA, Fidanza V, Huebner K, Rothstein JL 2001 Altered gene expression in immunogenic poorly differentiated thyroid carcinomas from RET= PTC3p53-=-mice. Oncogene 20:3235-3246.
146. Knauf JA, Ma X, Smith EP, Zhang L, Mitsutake N, Liao XH, Refetoff S, Nikiforov YE, Fagin JA 2005 Targeted expression of BRAFV600E in thyroid cells of transgenic mice results in papillary thyroid cancers that undergo dedifferentiation. Cancer Res 65:4238-4245.
147. Suzuki H, Willingham MC, Cheng SY 2002 Mice with a mutation in the thyroid hormone receptor beta gene spontaneously develop thyroid carcinoma: a mouse model of thyroid carcinogenesis. Thyroid 12:963-969.
148. Guigon CJ, Zhao L, Willingham MC, Cheng SY 2009 PTEN deficiency accelerates tumour progression in a mouse model of thyroid cancer. Oncogene 28:509-517.
149. Ribeiro-Neto F, Leon A, Urbani-Brocard J, Lou L, Nyska A, Altschuler DL 2004 cAMP-dependent oncogenic action of Rap1b in the thyroid gland. J Biol Chem 279:46868-46875.
150. Miller KA, Yeager N, Baker K, Liao XH, Refetoff S, Di Cristofano A 2009 Oncogenic Kras requires simultaneous PI3K signaling to induce ERK activation and transform thyroid epithelial cells in vivo. Cancer Res 69:3689-3694.
151. Yeager N, Klein-Szanto A, Kimura S, Di Cristofano A 2007 Pten loss in the mouse thyroid causes goiter and follicular adenomas: insights into thyroid function and Cowden disease pathogenesis. Cancer Res 67:959-966.
152. Ledent C, Coppee F, Dumont JE, Vassart G, Parmentier M 1996 Transgenic models for proliferative and hyperfunctional thyroid diseases. Exp Clin Endocrinol Diabetes 104 Suppl 3:43-46.
153. Michiels FM, Chappuis S, Caillou B, Pasini A, Talbot M, Monier R, Lenoir GM, Feunteun J, Billaud M 1997 Development of medullary thyroid carcinoma in transgenic mice expressing the RET protooncogene altered by a multiple endocrine neoplasia type 2A mutation. Proc Natl Acad Sci USA 94:3330-3335.
154. Johnston D, Hatzis D, Sunday ME 1998 Expression of v-Haras driven by the calcitonin=calcitonin gene-related peptide promoter: a novel transgenic murine model for medullary thyroid carcinoma. Oncogene 16:167-177.
155. Harvey M, Vogel H, Lee EY, Bradley A, Donehower LA 1995 Mice deficient in both p53 and Rb develop tumors primarily of endocrine origin. Cancer Res 55:1146-1151.
156. Coxon AB, Ward JM, Geradts J, Otterson GA, Zajac-Kaye M, Kaye FJ 1998 RET cooperates with RB=p53 inactivation in a somatic multi-step model for murine thyroid cancer. Oncogene 17:1625-1628.
157. Parlato R, Rosica A, Rodriguez-Mallon A, Affuso A, Postiglione MP, Arra C, Mansouri A, Kimura S, Di Lauro R, De Felice M 2004 An integrated regulatory network controlling survival and migration in thyroid organogenesis. Dev Biol 276:464-475.
158. Trueba SS, Auge J, Mattei G, Etchevers H, Martinovic J, Czernichow P, Vekemans M, Polak M, Attie-Bitach T 2005 PAX8, TITF1, and FOXE1 gene expression patterns during human development: new insights into human thyroid development and thyroid dysgenesis-associated malformations. J Clin Endocrinol Metab 90:455-462.
159. Di Palma T, D'Andrea B, Liguori GL, Liguoro A, de Cristofaro T, Del Prete D, Pappalardo A, Mascia A, Zannini M 2009 TAZ is a coactivator for Pax8 and TTF-1, two transcription factors involved in thyroid differentiation. Exp Cell Res 315:162-175.
160. Takano T, Miyauchi A, Yoshida H, Kuma K, Amino N 2004 High-throughput differential screening of mRNAs by serial analysis of gene expression: decreased expression of trefoil factor 3mRNA in thyroid follicular carcinomas. Br J Cancer 90:1600-1605.